Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income (loss) $ 59,767 $ 62,107
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for loss on receivables 12,481 6,222
Depreciation and amortization 2,746 2,938
Amortization of financing costs 9,347 8,666
Equity-based compensation 14,977 17,994
Equity method investments (937) (26,340)
Non-cash gain on securitization (34,080) (25,201)
(Gain) loss on sale of receivables and investments 1,305 (218)
Changes in receivables held-for-sale 40,183 5,466
Changes in accounts payable and accrued expenses 8,952 28,154
Change in accrued interest on receivables and investments (26,087) (10,077)
Other 3,686 (5,736)
Net cash provided by (used in) operating activities 92,340 63,975
Cash flows from investing activities    
Equity method investments (583,323) (143,645)
Equity method investment distributions received 20,259 99,599
Proceeds from sales of equity method investments 0 1,700
Purchases of and investments in receivables (1,016,467) (337,517)
Principal collections from receivables 167,406 106,695
Proceeds from sales of receivables 7,634 5,047
Purchases of real estate 0 (4,550)
Purchases of investments and securitization assets (14,404) (2,329)
Proceeds from sales of investments and securitization assets 0 7,020
Funding of escrow accounts 0 (228)
Withdrawal from escrow accounts 0 15,156
Other (285) (815)
Net cash provided by (used in) investing activities (1,419,180) (253,867)
Cash flows from financing activities    
Proceeds from credit facilities 777,000 100,000
Principal payments on credit facilities (342,000) (100,000)
Proceeds from issuance of term loan 200,000 0
Principal payments on term loan (9,575) 0
Proceeds from issuance of commercial paper notes 49,775 50,000
Proceeds from issuance of convertible notes 402,500 200,000
Principal payments on convertible notes (143,748) 0
Purchase of capped calls related to the issuance of convertible notes (37,835) 0
Net proceeds of common stock issuances 465,015 127,008
Payments of dividends and distributions (115,087) (98,310)
Withholdings on employee share vesting (1,466) (3,211)
Payment of financing costs (13,302) (8,203)
Receipt of hedge collateral 106,330 0
Other (2,493) (8,128)
Net cash provided by (used in) financing activities 1,320,400 237,029
Increase (decrease) in cash, cash equivalents, and restricted cash (6,440) 47,137
Cash, cash equivalents, and restricted cash at beginning of period 175,972 251,073
Cash, cash equivalents, and restricted cash at end of period 169,532 298,210
Interest paid 91,988 62,594
Supplemental disclosure of non-cash activity    
Residual assets retained from securitization transactions 26,020 25,374
Equity method investments received upon deconsolidation of a special purpose entity 144,603 0
Issuance of common stock from conversion of Convertible Notes 0 7,674
Deconsolidation of non-recourse debt 257,746 0
Deconsolidation of assets pledged for non-recourse debt 374,608 0
Non-recourse debt    
Cash flows from financing activities    
Principal payments on non-recourse debt $ (14,714) $ (22,127)